Stock A039840 DIO CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials DIO Corporation

Equities

A039840

KR7039840004

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
20,200 KRW +0.25% Intraday chart for DIO Corporation -2.42% -9.82%
Apr. 12 DIO Corporation announced that it has received KRW 70 billion in funding CI
Mar. 08 DIO Corporation announced that it expects to receive KRW 70 billion in funding CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 628,042 468,907 553,046 290,931 325,349 293,395 - -
Enterprise Value (EV) 2 679.3 527.4 631.2 380.2 427.5 291.4 284.2 293.4
P/E ratio 28.3 x 41.8 x 19.3 x -14.3 x 98.7 x 13 x 9.17 x 10.7 x
Yield - - - - - - - -
Capitalization / Revenue 4.94 x 3.91 x 3.69 x 2.22 x 2.09 x 1.87 x 1.42 x 1.38 x
EV / Revenue 5.34 x 4.39 x 4.21 x 2.9 x 2.74 x 1.85 x 1.38 x 1.38 x
EV / EBITDA 15.6 x 13.3 x 13.7 x 43.4 x 12.9 x 7.11 x 4.58 x 4.89 x
EV / FCF 70.7 x 74.9 x -48.9 x -32.3 x 352 x 6.62 x 5.98 x -
FCF Yield 1.42% 1.34% -2.04% -3.1% 0.28% 15.1% 16.7% -
Price to Book 4.32 x 2.9 x 2.92 x 1.75 x 1.68 x 1.21 x 1.07 x 1.14 x
Nbr of stocks (in thousands) 14,953 14,815 14,807 14,768 14,524 14,524 - -
Reference price 3 42,000 31,650 37,350 19,700 22,400 20,200 20,200 20,200
Announcement Date 2/18/20 1/27/21 2/28/22 2/22/23 1/19/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 127.2 120.1 150 131.3 155.8 157.1 206.5 212
EBITDA 1 43.61 39.55 46.22 8.764 33.21 41 62.05 60
EBIT 1 34.77 30.01 34.8 -4.405 20.9 29.55 39.93 46
Operating Margin 27.34% 24.99% 23.19% -3.36% 13.41% 18.81% 19.34% 21.7%
Earnings before Tax (EBT) 1 35.4 16.48 33.81 -21.08 10.41 21.8 43.5 37
Net income 1 25.6 11.15 28.12 -20.46 2.923 19.8 33.58 30
Net margin 20.13% 9.29% 18.74% -15.58% 1.88% 12.6% 16.26% 14.15%
EPS 2 1,483 758.0 1,932 -1,380 227.0 1,548 2,202 1,893
Free Cash Flow 3 9,615 7,043 -12,896 -11,774 1,215 44,000 47,500 -
FCF margin 7,561.12% 5,866.42% -8,594.97% -8,966.8% 779.98% 28,007.64% 23,002.42% -
FCF Conversion (EBITDA) 22,049.14% 17,807.69% - - 3,660.09% 107,317.07% 76,551.17% -
FCF Conversion (Net income) 37,556.59% 63,148.88% - - 41,579.02% 222,222.22% 141,474.31% -
Dividend per Share - - - - - - - -
Announcement Date 2/18/20 1/27/21 2/28/22 2/22/23 1/19/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 39.03 39.3 34.62 34.51 38.15 24.02 41.26 43.8 40.05 30.71 34.96 39.45 34.9 41.35 40.5
EBITDA - - - - - - - - - - - - - - -
EBIT 1 10.01 3.412 5.255 1.056 1.071 -11.79 10.13 10.23 6.512 -5.97 5.643 8.25 6.7 8.75 7.2
Operating Margin 25.64% 8.68% 15.18% 3.06% 2.81% -49.07% 24.55% 23.35% 16.26% -19.44% 16.14% 20.91% 19.2% 21.16% 17.78%
Earnings before Tax (EBT) 11.17 2.376 5.04 3.023 3.218 -32.36 14.67 5.093 6.01 - - 6.4 3.7 5.5 6.1
Net income 1 8.882 1.997 2.343 1.899 1.544 -26.24 11.31 2.857 3.454 -14.31 4.206 6.55 5.6 6.45 4.8
Net margin 22.76% 5.08% 6.77% 5.5% 4.05% -109.25% 27.42% 6.52% 8.63% -46.61% 12.03% 16.6% 16.05% 15.6% 11.85%
EPS - - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/2/21 2/28/22 5/13/22 8/16/22 11/14/22 2/22/23 5/15/23 7/20/23 11/14/23 1/19/24 5/16/24 - - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 51.3 58.5 78.2 89.3 102 - - -
Net Cash position 1 - - - - - 2 9.2 -
Leverage (Debt/EBITDA) 1.176 x 1.479 x 1.692 x 10.19 x 3.076 x - - -
Free Cash Flow 2 9,615 7,043 -12,896 -11,774 1,215 44,000 47,500 -
ROE (net income / shareholders' equity) 19.5% 7.46% 16.1% -11.3% 1.61% 11.1% 13% 11.3%
ROA (Net income/ Total Assets) 10.3% 3.84% 8.44% -6.03% 0.95% 5% 7.4% 5.6%
Assets 1 249.2 290.8 333.2 339.2 308 396 453.7 535.7
Book Value Per Share 3 9,717 10,913 12,783 11,237 13,356 16,682 18,920 17,698
Cash Flow per Share 3 657.0 1,299 427.0 - 374.0 3,360 3,775 -
Capex 1 16.3 11.4 17.4 10.7 4.22 13.6 15.4 19
Capex / Sales 12.82% 9.49% 11.62% 8.19% 2.71% 8.66% 7.47% 8.96%
Announcement Date 2/18/20 1/27/21 2/28/22 2/22/23 1/19/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for DIO Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
20,200 KRW
Average target price
33,750 KRW
Spread / Average Target
+67.08%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
DIO CORPORATION Stock DIO Corporation
-9.82% 214M
STRYKER CORPORATION Stock Stryker Corporation
+10.24% 128B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-8.89% 11.26B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+3.31% 9.28B
GLAUKOS CORPORATION Stock Glaukos Corporation
+35.16% 5.42B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-23.90% 4.8B
AXONICS, INC. Stock Axonics, Inc.
+8.20% 3.45B
ENOVIS CORPORATION Stock Enovis Corporation
-10.69% 2.8B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-12.15% 2.1B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-11.96% 1.98B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. A039840 Stock
  4. Financials DIO Corporation